TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$51.95
-2.92% today
Updated 2026-04-29
Market cap
$8.13B
P/E ratio
98.02
P/S ratio
6.69x
EPS (TTM)
$0.53
Dividend yield
0.60%
52W range
$46 – $72
Volume
2.2M
Bio-Techne Corp (TECH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $370.51M | $454.84M | $507.37M | $472.00M | $518.82M | $617.67M | $719.32M | $778.10M | $862.49M | $1.06B | $1.13B | $1.56B | $1.59B | $1.88B | $2.03B | $2.26B | $2.29B | $2.64B | $2.70B | $2.56B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $149.82M | $212.84M | $258.43M | $255.47M | $201.04M | $230.42M | $346.51M | $409.52M | $469.41M | $248.28M | $253.89M | $345.26M | $398.37M | $412.61M | $520.92M | $510.61M | $605.56M | $621.48M | $617.42M | $608.30M |
| Total liabilities | $30.16M | $17.19M | $20.24M | $15.52M | $17.02M | $31.55M | $44.88M | $40.56M | $67.23M | $216.43M | $250.23M | $605.83M | $514.06M | $718.82M | $646.40M | $691.72M | $593.79M | $672.18M | $635.02M | $639.06M |
| Current liabilities | $17.97M | $17.19M | $20.24M | $15.52M | $17.02M | $18.19M | $35.75M | $32.08M | $26.39M | $39.77M | $54.15M | $135.36M | $78.69M | $101.98M | $106.67M | $152.28M | $176.02M | $128.51M | $159.38M | $175.85M |
| Long-term debt | $12.20M | — | — | — | — | $0.00 | $0.00 | $0.00 | $7.00M | $73.00M | $91.50M | $343.77M | $339.00M | $492.66M | $344.24M | $328.83M | $243.41M | $350.00M | $319.00M | $346.00M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $232.33M | $314.34M | $359.21M | $345.64M | $400.12M | $472.73M | $520.45M | $587.73M | $653.28M | $713.85M | $770.55M | $799.03M | $876.93M | $931.93M | $1.06B | $1.09B | $1.12B | $1.31B | $1.33B | $1.07B |
| Accounts receivable | $25.08M | $30.97M | $33.33M | $31.15M | $34.14M | $37.86M | $37.74M | $40.17M | $55.00M | $70.03M | $93.39M | $116.83M | $120.30M | $137.47M | $122.53M | $145.38M | $194.55M | $218.47M | $241.39M | $206.88M |
| Inventory | $9.02M | $8.76M | $9.52M | $11.27M | $13.74M | $44.91M | $38.28M | $34.88M | $38.85M | $49.58M | $57.10M | $60.15M | $85.65M | $91.05M | $103.15M | $116.75M | $141.12M | $171.64M | $179.73M | $189.45M |
| Goodwill | $25.31M | $25.07M | $25.07M | $25.07M | $25.07M | $86.63M | $85.68M | $84.34M | $151.47M | $390.64M | $430.88M | $579.03M | $597.89M | $732.67M | $728.31M | $843.07M | $822.10M | $872.74M | $972.66M | $980.93M |